Perinatal Stroke and Cerebral Sinovenous Thrombosis Caused by Congenital Nephrotic Syndrome NPSH1 (Finnish Type): A Case Report

Abstract

Congenital nephrotic syndrome (CNS) is a severe renal disorder in newborns, characterized by complications such as albuminuria, hypoalbuminemia, and hypercoagulability. While CNS is known to predispose patients to thrombosis over time, to our knowledge, cerebrovascular complications such as cerebral sinovenous thrombosis (CSVT) within the first week after birth have rarely been reported before in neonates with confirmed CNS. We present here an infant, born by normal vaginal delivery, which was complicated by the retention of a large placenta. She was first admitted on day 3 with perioral cyanosis and polycythemia. She developed apneas that were later confirmed with amplitude integrated EEG to be seizures and was found to have multiple thrombotic complications, including extensive CSVT and bilateral thalamic hemorrhages. Serum albumin level was very low, with high urinary levels suspicious for Finnish-type CNS, which was confirmed by NPHS1 pathogenic variants p.Cys623Phe and p.Asn870Profs*36. Despite partial exchange transfusions and anticoagulation therapy, the infant developed severe cerebral abnormalities. This case underscores the importance of considering CNS in neonates with a large placenta, severe polycythemia, proteinuria, and hypoalbuminemia, as they may be at risk of developing CSVT.

Keywords

congenital nephrotic syndrome - cerebral sinovenous thrombosis - thalamic hemorrhage

Publication History

Received: 26 February 2025

Accepted: 14 July 2025

Accepted Manuscript online:
16 July 2025

Article published online:
28 July 2025

• References

• 1 Hinkes BG, Mucha B, Vlangos CN. et al.; Arbeitsgemeinschaft für Paediatrische Nephrologie Study Group. Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 2007; 119 (04) e907-e919
• 2 Reynolds BC, Oswald RJA. Diagnostic and management challenges in congenital nephrotic syndrome. Pediatric Health Med Ther 2019; 10: 157-167
• 3 Wang JJ, Mao JH. The etiology of congenital nephrotic syndrome: current status and challenges. World J Pediatr 2016; 12 (02) 149-158
• 4 Fofah O, Roth P. Congenital nephrotic syndrome presenting with cerebral venous thrombosis, hypocalcemia, and seizures in the neonatal period. J Perinatol 1997; 17 (06) 492-494
• 5 Horsch S, Schaper J, Roll C. Lesions in congenital nephrotic syndrome. J Pediatr 2007; 151 (02) 221
• 6 Jalanko H. Congenital nephrotic syndrome. Pediatr Nephrol 2009; 24 (11) 2121-2128
• 7 Schwarz H, Kohn JL. Lipoid nephrosis: A clinical and pathologic study based on fifteen years observation with special reference to prognosis. Am J Dis Child 1935; 49 (03) 579-593
• 8 Igarashi M, Roy III S, Stapleton FB. Cerebrovascular complications in children with nephrotic syndrome. Pediatr Neurol 1988; 4 (06) 362-365
• 9 Konopásek P, Piteková B, Krejčová V, Zieg J. Cerebral sinovenous thrombosis in children with nephrotic syndrome: systematic review and one new case. Front Pediatr 2023; 11: 1207871
• 10 Ranganathan S. Pathology of podocytopathies causing nephrotic syndrome in children. Front Pediatr 2016; 4: 32
• 11 Hamasaki Y, Hamada R, Muramatsu M. et al. A cross-sectional nationwide survey of congenital and infantile nephrotic syndrome in Japan. BMC Nephrol 2020; 21 (01) 363
• 12 Boyer O, Schaefer F, Haffner D. et al. Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group. Nat Rev Nephrol 2021; 17 (04) 277-289
• 13 Patrakka J, Martin P, Salonen R. et al. Proteinuria and prenatal diagnosis of congenital nephrosis in fetal carriers of nephrin gene mutations. Lancet 2002; 359 (9317) 1575-1577